Menarini launches premature ejaculation drug in Singapore

Posted on

New Drug Approvals

File:Dapoxetine Structural Formulae V.1.svg

DAPOXETINE

Menarini has launched dapoxetine for premature ejaculation in Singapore, having recently published a survey highlighting the rising problem of sexual dissatisfaction in the Asia-Pacific region.

The Italian drugmaker acquired Priligy (dapoxetine)from Johnson & Johnson last year and the drug is now approved in over 50 countries. It estimates that PE affects 34% of men in Singapore at some point in their lives.

READ  ALL AT

http://www.pharmatimes.com/Article/13-07-19/Menarini_launches_premature_ejaculation_drug_in_Singapore.aspx

Dapoxetine, marketed as Priligy (among and other brands) is the first compound developed specially for the treatment of premature ejaculation (PE) in men 18–64 years old.Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin’s action at the post synaptic cleft, and as a consequence promoting ejaculatory delay. As a member of selective serotonin reuptake inhibitor (SSRI) family, dapoxetine was initially created as an antidepressant. However, unlike other SSRIs, dapoxetine is absorbed and eliminated rapidly in the body…

View original post 362 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s